USX:MYNZ - Mainz Biomed BV Mainz Biomed BV
Sector: Health Care, Industry: Life Sciences Tools & Services
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 10.12    +0.52 (+5.42%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

24 Jun 2022


Loading...
Loading...
Loading...

General

CEO: Mr. Guido Baechler

IPO: 2021-11-05

Headquarters: US

Employees: 0

Homepage

Description

Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.

Your Holdings
Dashboard
Portfolio
Options
Other Assets

Tools
Screener
Risk Manager
Other Assets
Watchlist
Alerts
Notes
Wall
Community
Forum
Blogs
Instagram
Facebook
Shared Portfolios
Shared Screeners

Collab
Tiger Brokers x StocksCafe
Saxo Trading x StocksCafe
Kenny REIT Screener

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
IG    FB    YouTube

About · FAQs · StocksCafe © 2022 · Privacy · Terms